FindTrial
Sign In

Registry Study of Ischemic Optic Neuropathy

Registry Study of Ischemic Optic Neuropathy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600124284
Enrollment
Unknown
Registered
2026-05-09
Start date
2026-06-01
Completion date
Unknown
Last updated
2026-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nonarteritic Anterior Ischemic Optic Neuropathy

Interventions

A group:Patients treated with endoscopic transnasal optic nerve decompression
B group:None

Sponsors

Eye Hospital, Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with "ischemic optic neuropathy"; 2. Patients who have been treated with any one or more of the following: hormones, neurotrophic drugs, or "endoscopic transnasal optic nerve decompression surgery".

Exclusion criteria

Exclusion criteria: 1. Patients who have not been treated with any of the following: hormones, neurotrophic drugs, or 'endoscopic transnasal optic nerve decompression surgery'; 2. Patients without postoperative follow-up; 3. Patients who refuse to participate in the study.

Design outcomes

Primary

MeasureTime frame
Best vision correction;—

Secondary

MeasureTime frame
visual field;OCTA vessel density;—

Countries

China

Contacts

Public ContactWu Wencan

Eye Hospital, Wenzhou Medical University

wuwencan118@163.com+86 577 81152625

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 16, 2026